Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract

Guangzhen Hu, Jessica L. Phillips, Surendra Dasari, Hailey K. Jacobs, Rebecca A. Luchtel, Naoki Oishi, Tanya Hundal, Nada H. Ahmed, Akira Satou, Alan L. Epstein, N. Nora Bennani, Grzegorz S. Nowakowski, Joseph A. Murray, Andrew L. Feldman

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1467-1471
Number of pages5
JournalLeukemia
Volume34
Issue number5
DOIs
StatePublished - May 1 2020

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Hu, G., Phillips, J. L., Dasari, S., Jacobs, H. K., Luchtel, R. A., Oishi, N., Hundal, T., Ahmed, N. H., Satou, A., Epstein, A. L., Bennani, N. N., Nowakowski, G. S., Murray, J. A., & Feldman, A. L. (2020). Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract. Leukemia, 34(5), 1467-1471. https://doi.org/10.1038/s41375-019-0678-3